Oxford Instruments NanoScience has announced its partnership in three major projects funded through Innovate UK’s ‘Commercialising Quantum Technologies’ category with industry-leading organisations SEEQC, Quantum Motion and sureCore.
Oxford Instruments NanoScience designs research tools that enable quantum technologies, new materials and device development in the physical sciences. Its tools support research down to the atomic scale through creation of high performance, cryogen-free low temperature and magnetic environments, based upon its core technologies in low and ultra-low temperatures, high magnetic fields and system integration.
Oxford Instruments NanoScience, which is part of the Oxford Instruments plc group, has partnered with SEEQC on its Industrial Strategy Challenge Fund (ISCF) QuPharma project with £6.8M funding to build a commercially scalable application-specific quantum computer for science and technology company, Merck KGaA in Darmstadt, Germany. By supplying its cryogenic engineering expertise and a custom cryostat with unique capabilities, SEEQC will be able to manufacture a quantum computer platform for Merck KGaA to help them make advancements in the research and development of next-generation pharmaceutical therapies and performance materials.
Oxford Instruments NanoScience has also partnered with Oxford based Quantum Motion in a £5.7M funded project called ‘Altnaharra’, based on the development of quantum computing technology using superconducting circuits, ion traps, and spin qubits. The project’s focus is developing cryoelectronics for quantum circuits, and will target the development of cryogenic chips for integrated qubit control and readout, manufactured in a standard complementary metal-oxide-semiconductor (CMOS) foundry.
Third, Oxford Instruments NanoScience has a £6.5M funded project led by sureCore that focuses on the development of cryo-CMOS electronics and will allow for the development of the memory and control architecture for local control and measurement of qubits. This is to simplify architecture and reduce the number of wires for the quantum information processor – factors that are limiting the scalability of future quantum devices, along with reducing the cost of current qubit control. The consortium will create process design kits necessary to facilitate the design of silicon-based CMOS circuits optimised for quantum computing applications and operating at cryogenic temperatures, while manufactured using conventional foundries. Oxford Instruments NanoScience will support the endeavour by supplying cryogenics design expertise to facilitate cryo-CMOS solutions for new design rules.
Matthew Martin, Director of Engineering at Oxford Instruments NanoScience, said: “We are pleased to be a direct partner in three major Innovate UK projects to bring the commercialisation of quantum computing closer for meaningful enterprise applications. With our proven history of delivering complex technology, we are able to partner with leading organisations to accelerate research and discovery in vital industries such as pharmaceuticals. We look forward to working with Quantum Motion, sureCore and SEEQC and will also continue to grow our international partnerships to deliver our technology roadmap. Collectively, the aggregation of world-leading skills will resolve the challenges to scale up and commercialisation, delivering the implementation of quantum computing to real-world applications for life-changing outcomes.”